LIVN logo

LivaNova (LIVN)

Profile

Full Name

LivaNova PLC

Ticker Symbol

LIVN

Exchange

NASDAQ

Sector

Healthcare

Industry

Medical Devices

Country

United Kingdom

IPO

October 19, 2015

Indexes

Not included

Website

http://www.livanova.com

Employees

2900

Key Details

Price

$35.48(+1.17%)

Market cap

Last Dividend

-

TTM Dividend yield

-

Annual revenue

$1.25B(+8.66% YoY)

Annual EPS

$1.16(+262.50% YoY)

PE ratio

31.12

Next earnings date

May 7, 2025

Next ex-dividend date

N/A

Next split date

N/A

Price

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Current Price

$35.48
LIVN price is $35.48

30-Day Relative Volume

0.71
LIVN 30-day relative volume is 0.71

Price Performance

Price Today change

+1.17%
LIVN price is up +1.17% today

Price YTD change

-23.39%
LIVN price is down -23.39% since January 1st

Price 1-year change

-31.6%
LIVN price is down -31.6% year-on-year

Price 3-year change

-56.53%
LIVN price is down -56.53% over the past 3 years

Price Range

Price All-time high

$131.54
LIVN price is currently -73.03% below its historical high of $131.54

Price 3-year low

$32.48
LIVN price is currently +9.24% above its 3-year low

Capitalization

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Market cap

Market cap

$1.93B
LIVN market capitalization is $1.93 billion

Market cap 3-year change

-55.79%
LIVN market capitalization is down -55.79% over the past 3 years

Market cap All-time high

$6.36B
LIVN market capitalization is currently -69.69% below its historical high of $6.36 billion

Market cap sector rank

83.22%
LIVN market capitalization is higher than 83.22% of companies in Healthcare sector

Shares Outstanding

Shares Outstanding 1-Year Change

+0.37%
LIVN shares outstanding is up +0.37% year-on-year

Shares Outstanding 3-Year Change

+1.71%
LIVN shares outstanding is up +1.71% over the past 3 years

Technical Indicators

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Beta

0.71
LIVN beta is 0.71

200-day SMA

$47.88
LIVN price is currently -25.89% below its 200-day simple moving average

50-day SMA

$41.13
LIVN price is currently -13.74% below its 50-day simple moving average

RSI

37.88
LIVN 14-day relative strength index is 37.88

Volume

0.71
LIVN 30-day relative volume is 0.71

ATR

$1.90
LIVN average true range is $1.90

10-day Historical Volatility

59.32%
LIVN 10-day historical volatility is 59.32%

Dividend

Income Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Revenue

Revenue

$1.25B
LIVN annual revenue is $1.25 billion

Revenue Analysts estimate

$1.30B
LIVN annual revenue is currently -3.59% lower than the consensus analysts' forecast

Revenue 1-year change

+8.66%
LIVN annual revenue is up +8.66% year-on-year

Revenue Sector rank

82.31%
LIVN annual revenue is higher than 82.31% of companies in Healthcare sector

EPS

EPS

$1.16
LIVN annual earnings per share is $1.16

EPS Analysts estimate

$3.60
LIVN annual earnings per share is currently -67.74% lower than the consensus analysts' forecast

EPS 1-year change

+262.5%
LIVN annual earnings per share is up +262.5% year-on-year

EPS Sector rank

89.92%
LIVN annual earnings per share is higher than 89.92% of companies in Healthcare sector

Profit

Gross profit

$870.87M
LIVN annual gross profit is $870.87 million

Gross margin

69.48%
LIVN annual gross profit margin is 69.48%

Operating profit

$129.05M
LIVN annual operating income is $129.05 million

Operating margin

10.30%
LIVN annual operating profit margin is 10.30%

Net income

$63.23M
LIVN annual net profit is $63.23 million

Net margin

5.04%
LIVN annual net profit margin is 5.04%

Expenses

Total expenses

$1.12B
LIVN annual total expenses is $1.12 billion

Operating expenses

$741.82M
LIVN annual total operating expenses is $741.82 million

Cost of goods sold

$382.56M
LIVN annual cost of goods sold is $382.56 million

Selling, general & administrative expenses

$526.26M
LIVN annual SGA is $526.26 million

Depreciation and amortization

$51.14M
LIVN annual depreciation & amortization is $51.14 million

Interest expense

$63.07M
LIVN annual interest expense is $63.07 million

Income tax

$25.06M
LIVN annual income tax is $25.06 million

EBIT & EBITDA

EBIT

$151.38M
LIVN annual earnings before interest & taxes is $151.38 million

EBITDA

$202.52M
LIVN annual EBITDA is $202.52 million

Balance Sheet

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Assets

Total assets

$2.51B
LIVN annual total assets is $2.51 billion

Non current assets

$1.38B
LIVN annual long term assets is $1.38 billion

Current assets

$1.13B
LIVN annual total current assets is $1.13 billion

Cash and cash equivalents

$428.86M
LIVN annual cash & cash equivalents is $428.86 million

Accounts receivable

$193.16M
LIVN annual accounts receivable is $193.16 million

Inventory

$147.57M
LIVN annual inventory is $147.57 million

Liabilities

Total liabilities

$1.19B
LIVN annual total liabilities is $1.19 billion

Long term liabilities

$794.01M
LIVN annual total long term liabilities is $794.01 million

Current liabilities

$392.13M
LIVN annual total current liabilities is $392.13 million

Accounts payable

$69.73M
LIVN annual accounts payable is $69.73 million

Debt

Total debt

$676.77M
LIVN annual total debt is $676.77 million

Total debt 1-year change

+5.68%
LIVN annual total debt is up +5.68% year-on-year

Long term debt

$589.73M
LIVN annual long term debt is $589.73 million

Short term debt

$87.04M
LIVN annual short term debt is $87.04 million

Equity & Capital

Shareholders equity

$1.32B
LIVN annual stockholders equity is $1.32 billion

Book value

$1.32B
LIVN annual book value is $1.32 billion

Retained earnings

-$903.25M
LIVN annual retained earnings is -$903.25 million

Working capital

$735.06M
LIVN annual working capital is $735.06 million

Cash Flow Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cashflow Activities

Cash from operations

$183.04M
LIVN annual cash flow from operations is $183.04 million

Cash from operations 1-year change

+144.33%
LIVN annual cash flow from operations is up +144.33% year-on-year

Cash from investing

-$48.16M
LIVN annual cash flow from investing activities is -$48.16 million

Cash from investing 1-year change

-19.41%
LIVN annual cash flow from investing activities is down -19.41% year-on-year

Cash from financing

$18.55M
LIVN annual cash flow from financing activities is $18.55 million

Cash from financing 1-year change

-13.65%
LIVN annual cash flow from financing activities is down -13.65% year-on-year

CAPEX

CAPEX

$47.11M
LIVN annual capital expenditures is $47.11 million

CAPEX 1-year change

+34.66%
LIVN annual capital expenditures is up +34.66% year-on-year

Free Cash Flow

Free cash flow

$135.93M
LIVN annual free cash flow is $135.93 million

Free cash flow 1-year change

+240.4%
LIVN annual free cash flow is up +240.4% year-on-year

Profitability Ratios

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Margins

Gross margin

69.48%
LIVN annual gross profit margin is 69.48%

Operating margin

10.30%
LIVN annual operating profit margin is 10.30%

Net margin

5.04%
LIVN annual net profit margin is 5.04%

ROA & ROE

ROA

2.56%
LIVN annual return on assets is 2.56%

ROE

4.87%
LIVN annual return on equity is 4.87%

Valuation

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

PE Ratio

PE ratio

31.12
LIVN price to earnings ratio is 31.12

PE ratio Sector rank

63.24%
LIVN price to earnings ratio is higher than 63.24% of companies in Healthcare sector

PB Ratio

PB ratio

1.46
LIVN price to book ratio is 1.46

PB ratio Sector rank

54.94%
LIVN price to book ratio is higher than 54.94% of companies in Healthcare sector

PS Ratio

PS ratio

1.54
LIVN price to sales ratio is 1.54

PS ratio Sector rank

36.92%
LIVN price to sales ratio is higher than 36.92% of companies in Healthcare sector

Enterprise value

Enterprise value

$2.18B
LIVN enterprise value is $2.18 billion

Enterprise value Sector rank

82.91%
LIVN enterprise value is higher than 82.91% of companies in Healthcare sector

EV/EBITDA

EV/EBITDA

10.75
LIVN EV/EBITDA is 10.75

EV/EBITDA Sector rank

83.13%
LIVN EV/EBITDA is higher than 83.13% of companies in Healthcare sector

Financial Health

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Liquidity

Current ratio

2.87
LIVN annual current ratio is 2.87

Quick ratio

2.50
LIVN annual quick ratio is 2.50

Leverage

Debt to equity

0.48
LIVN annual debt to equity ratio is 0.48

Interest coverage ratio

2.40
LIVN annual interest coverage ratio is 2.40

Risk & Stability

Piotroski F-Score

7
LIVN piotroski f-score is 7

Altman Z-Score

1.52
LIVN altman z-score is 1.52

Analyst ratings

Recent major analysts updates

Mar 17, 25 Needham
Buy
Mar 7, 25 Barclays
Equal-Weight
Mar 3, 25 Goldman Sachs
Buy
Feb 26, 25 Stifel
Buy
Feb 26, 25 Needham
Buy
Feb 26, 25 Mizuho
Outperform
Jan 28, 25 Needham
Buy
Nov 25, 24 Needham
Buy
Nov 12, 24 Needham
Buy
Oct 31, 24 Needham
Buy

Institutional Ownership

Similar stocks

BHVN logo
Biohaven (BHVN)
LMAT logo
LeMaitre Vascular (LMAT)
MIRM logo
Mirum Pharmaceuticals (MIRM)
TARS logo
Tarsus Pharmaceuticals (TARS)
CLOV logo
Clover Health Investments (CLOV)
APGE logo
Apogee Therapeutics (APGE)
Belite Bio (BLTE)
Metsera (MTSR)
SDGR logo
Schrödinger (SDGR)
  • What is the ticker symbol for LivaNova?
  • Does LivaNova pay dividends?
  • What sector is LivaNova in?
  • What industry is LivaNova in?
  • What country is LivaNova based in?
  • When did LivaNova go public?
  • Is LivaNova in the S&P 500?
  • Is LivaNova in the NASDAQ 100?
  • Is LivaNova in the Dow Jones?
  • When was LivaNova's last earnings report?
  • When does LivaNova report earnings?
  • Should I buy LivaNova stock now?

What is the ticker symbol for LivaNova?

The ticker symbol for LivaNova is NASDAQ:LIVN

Does LivaNova pay dividends?

No, LivaNova does not pay dividends

What sector is LivaNova in?

LivaNova is in the Healthcare sector

What industry is LivaNova in?

LivaNova is in the Medical Devices industry

What country is LivaNova based in?

LivaNova is headquartered in United Kingdom

When did LivaNova go public?

LivaNova's initial public offering (IPO) was on October 19, 2015

Is LivaNova in the S&P 500?

No, LivaNova is not included in the S&P 500 index

Is LivaNova in the NASDAQ 100?

No, LivaNova is not included in the NASDAQ 100 index

Is LivaNova in the Dow Jones?

No, LivaNova is not included in the Dow Jones index

When was LivaNova's last earnings report?

LivaNova's most recent earnings report was on Feb 25, 2025

When does LivaNova report earnings?

The next expected earnings date for LivaNova is May 7, 2025

Should I buy LivaNova stock now?

As of today, analysts generally recommend a 'Buy' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions
On this page